PACB Pacific Biosciences of California Inc.

PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider

PacBio Names Global Institute for Food Security as Canada's First Revio Certified Service Provider

MENLO PARK, Calif., Jan. 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the Global Institute for Food Security (GIFS) at the University of Saskatchewan (USask) as the first Revio PacBio Certified Service Provider (CSP) in Canada.

Known for its leadership in animal, microbial and plant genomics, GIFS offers PacBio’s HiFi sequencing technology through its Omics and Precision Analytics Laboratory (OPAL) platform. This provides researchers across Canada and around the world with access to highly accurate long-read sequencing data to support complex genetic studies and practical applications, from agricultural innovation to disease discovery.

The PacBio Certified Service Provider program ensures that customers worldwide have access to the highest quality sequencing services powered by PacBio technology. By achieving CSP status, GIFS has demonstrated the capability, expertise, and infrastructure required to deliver high-quality PacBio sequencing solutions, including complex genome assemblies, transcriptomics, epigenetics, and other precision applications.

“Canada is home to a dynamic genomics research community that plays a key role in addressing global challenges such as food security, agricultural sustainability, and precision health,” said James Hudson, Senior Director of Americas Sales at PacBio. “We are proud to welcome GIFS as Canada’s first Revio PacBio Certified Service Provider. This certification provides Canadian researchers access to PacBio’s highly accurate HiFi sequencing technology through a trusted partner, enabling them to generate critical insights with exceptional precision and quality.”

GIFS’ OPAL platform provides full-service genomics solutions that include automation, bioinformatics, and advanced data analysis, positioning them as a valuable resource for researchers looking to tackle large-scale genomic projects. Through PacBio’s HiFi sequencing technology, GIFS will empower scientists to address emerging challenges.

“The Global Institute for Food Security’s world-class technology platforms help researchers and organizations to scale and accelerate their research and development. As a PacBio Certified Service Provider, our partners know they can depend on GIFS to deliver high-quality, HiFi data to advance their projects,” said Dr. Steven Webb (PhD), GIFS CEO. “Today, GIFS’ Omics and Precision Analytics Laboratory uses high-throughput automated workflows to help our partners get the most from PacBio’s long-read sequencing technologies. The sequencing results we deliver are supported by GIFS’ automated bioinformatics and visualizations pipelines, ensuring our partners receive both high-quality data and critical analysis that can help them to discover, develop, and deliver.” 

For more on the comprehensive services that GIFS provides, see .

The addition of GIFS to PacBio’s growing Certified Service Provider network highlights PacBio’s commitment to making its advanced sequencing solutions accessible to researchers worldwide.

About PacBio

PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our HiFi long-read sequencing and our SBB® short-read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit  and follow @PacBio.

PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.

About the Global Institute for Food Security at the University of Saskatchewan

The Global Institute for Food Security (GIFS) at the University of Saskatchewan (USask) works with partners to discover, develop, and deliver innovative solutions for the production of globally sustainable food. Serving as ‘agriculture’s innovation catalyst,’ GIFS is connecting the agri-food ecosystem, advancing innovation, and bridging the gap to commercialization to deliver resilient and sustainable food security for all stakeholders. For more information, visit .

Forward Looking Statements

This press release may contain “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are forward-looking statements, including statements relating to the uses, coverage, advantages, and benefits or expected benefits of using, PacBio products or technologies, including the ability of GIFS to deliver high-quality sequencing solutions; enabling researchers to generate critical insights and address emerging challenges using PacBio technology through GIFS; and other future events. You should not place undue reliance on forward-looking statements because they are subject to assumptions, risks, and uncertainties and could cause actual outcomes and results to differ materially from currently anticipated results, including, the difficulty of generating discoveries in complicated areas of biology; potential performance, quality and regulatory issues; and third-party claims alleging infringement of patents and proprietary rights or seeking to invalidate PacBio's patents or proprietary rights. Additional factors that could materially affect actual results can be found in PacBio's most recent filings with the Securities and Exchange Commission, including PacBio's most recent reports on Forms 8-K, 10-K, and 10-Q, and include those listed under the caption "Risk Factors." These forward-looking statements are based on current expectations and speak only as of the date hereof; except as required by law, PacBio disclaims any obligation to revise or update these forward-looking statements to reflect events or circumstances in the future, even if new information becomes available.

Contacts:

PacBio

For investors:

Todd Friedman,

For media:

Global Institute for Food Security:

Communications:

Dan Yates,



EN
23/01/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pacific Biosciences of California Inc.

 PRESS RELEASE

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequenc...

PacBio Joins the 1000 Genomes Long Read Project to Add Isoform Sequencing with Kinnex and Revio New Iso-Seq data from ~1,000 samples to expand transcriptomic insights using highly accurate HiFi sequencing MENLO PARK, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced it has joined the 1000 Genomes Long Read Sequencing Project, which will involve contributing long-read transcriptome data to one of the world’s most expansive human genomics initiatives. In collaboration with the laborat...

 PRESS RELEASE

PacBio to Report Second Quarter 2025 Financial Results on August 7, 20...

PacBio to Report Second Quarter 2025 Financial Results on August 7, 2025 MENLO PARK, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2025 financial results on Thursday, August 7, 2025, at 5:00 pm Eastern Time. The call will be webcast and may be accessed at PacBio’s website at . Date: Thursday, August 7, 2025, at 5:00 pm ET (2:00 pm PT)Listen live via internet or replay: Toll-free: 1-888-349-0136International: 1-412-317-0459 If using the dial-in option, please join the call ten...

 PRESS RELEASE

PacBio to Present at Upcoming Investor Conferences

PacBio to Present at Upcoming Investor Conferences MENLO PARK, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences: Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 8:45 AM ET in New York, NY46th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 11, 2025, at 10:40 AM ET in Miami Beach, FL Live webcasts of the events can be accessed at the company’s investors page ...

 PRESS RELEASE

PacBio Expands Distribution in China, Gaining Access to New Clinical L...

PacBio Expands Distribution in China, Gaining Access to New Clinical Lab Networks via Haorui Gene Haorui’s established footprint brings HiFi sequencing to new customers including hospital labs and regional blood centers MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally recognized leader in blood typing genomics, as an official distributor in China. The distribution arrangement is designed to expand access to PacBio’s HiFi long-rea...

 PRESS RELEASE

PacBio Board Independent Investigation Concludes Allegations Unsubstan...

PacBio Board Independent Investigation Concludes Allegations Unsubstantiated MENLO PARK, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced that the Special Committee of its Board of Directors (the “Special Committee”) has concluded its independent investigation into previously disclosed allegations from an attorney representing an employee impacted by our recent reduction in force regarding certain employment practices and cybersecurity matters of the Company. The allegations did not involve the current, or any previously reported, financial results, and the i...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch